| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |